APA (7th ed.) Citation

A, P., M, D., K, K., E, C., G, D., AK, E., . . . J, K. (2023). Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease. Minerva endocrinology, 48(3), 346. https://doi.org/10.23736/S2724-6507.21.03564-8

Chicago Style (17th ed.) Citation

A, Papaefthymiou, et al. "Effect of Spironolactone on Pharmacological Treatment of Nonalcoholic Fatty Liver Disease." Minerva Endocrinology 48, no. 3 (2023): 346. https://doi.org/10.23736/S2724-6507.21.03564-8.

MLA (9th ed.) Citation

A, Papaefthymiou, et al. "Effect of Spironolactone on Pharmacological Treatment of Nonalcoholic Fatty Liver Disease." Minerva Endocrinology, vol. 48, no. 3, 2023, p. 346, https://doi.org/10.23736/S2724-6507.21.03564-8.